MetS myocardium shows significant increases in content of clotting effectors: factor VIII (p = 0.049), factor X (p = 0.021), factor IX (p = 0.062) and factor XIIIa (p = 0.059) (Fig. 2a). This evidence concerns the gene F10 and metabolic syndrome.